HFS
TECH icon

Hantz Financial Services’s Bio-Techne TECH Stock Holding History

Hantz Financial Services’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226K Sell
3,199
-13,554
-81% -$732K ﹤0.01% 1056
2026
Q1 		$876K Sell
16,753
-1,231
-7% -$73.9K 0.01% 511
2025
Q4 		$1.06M Buy
17,984
+1,973
+12% +$120K 0.02% 469
2025
Q3 		$891K Buy
16,011
+3,537
+28% +$189K 0.01% 478
2025
Q2 		$642K Sell
12,474
-2,189
-15% -$110K 0.01% 490
2025
Q1 		$860K Buy
14,663
+467
+3% +$31.6K 0.02% 444
2024
Q4 		$1.02M Buy
14,196
+236
+2% +$17.3K 0.02% 434
2024
Q3 		$1.12M Buy
13,960
+834
+6% +$62.7K 0.02% 428
2024
Q2 		$940K Buy
13,126
+47
+0.4% +$3.46K 0.02% 442
2024
Q1 		$921K Sell
13,079
-494
-4% -$35.3K 0.02% 446
2023
Q4 		$1.05M Sell
13,573
-643
-5% -$42.4K 0.02% 425
2023
Q3 		$968K Buy
14,216
+544
+4% +$43K 0.02% 416
2023
Q2 		$1.12M Buy
13,672
+271
+2% +$21.8K 0.03% 389
2023
Q1 		$994K Buy
13,401
+999
+8% +$77K 0.03% 389
2022
Q4 		$1.03M Buy
12,402
+1,374
+12% +$109K 0.03% 375
2022
Q3 		$783K Buy
11,028
+2,712
+33% +$234K 0.03% 390
2022
Q2 		$721K Buy
8,316
+912
+12% +$85.5K 0.02% 398
2022
Q1 		$802K Buy
7,404
+1,028
+16% +$106K 0.02% 400
2021
Q4 		$825K Buy
6,376
+1,232
+24% +$151K 0.02% 390
2021
Q3 		$623K Buy
5,144
+1,604
+45% +$195K 0.02% 390
2021
Q2 		$398K Buy
3,540
+528
+18% +$55.6K 0.01% 407
2021
Q1 		$288K Sell
3,012
-36
-1% -$3.28K 0.01% 416
2020
Q4 		$242K Sell
3,048
-80
-3% -$5.79K 0.01% 391
2020
Q3 		$194K Buy
3,128
+8
+0.3% +$520 0.01% 380
2020
Q2 		$206K Hold
3,120
– – 0.01% 367
2020
Q1 		$148K Buy
+3,120
New +$156K 0.01% 372

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hantz Financial Services's TECH Position: Q2 2026 in Review

Hantz Financial Services reduced its Bio-Techne (TECH) stake by 81% in Q2 2026, selling an estimated $732K and leaving 3,199 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #1056.

Hantz Financial Services first reported a position in TECH in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.12M in Q3 2024. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Hantz Financial Services held 3,199 shares of Bio-Techne worth $226K as of Q2 2026.
  • Hantz Financial Services sold 13,554 Bio-Techne shares in Q2 2026, an estimated $732K.
  • Bio-Techne made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1056 holding.
  • Hantz Financial Services first reported a position in Bio-Techne in Q1 2020 and has held it in 26 quarters since.
  • Hantz Financial Services's Bio-Techne position peaked at $1.12M in Q3 2024.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.